Format

Send to

Choose Destination
Cytokine Growth Factor Rev. 1996 Aug;7(2):133-41.

The epidermal growth factor receptor and its ligands as therapeutic targets in human tumors.

Author information

1
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. ruschv@mskcc.org

Abstract

The epidermal growth factor receptor (EGFR) is detected on many non-haematopoietic tissues and is frequently overexpressed in human tumors. With its ligand, TGF-alpha, it forms a well-defined autocrine growth loop. Several clinical approaches, using EGFR as a therapeutic target, are being investigated, particularly monoclonal antibodies combined with chemotherapy, and pharmacological inhibition of downstream components of the EGFR signaling pathway.

PMID:
8899291
DOI:
10.1016/1359-6101(96)00016-0
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center